94 results
Page 3 of 5
8-K
EX-10.1
14jdb
7 Aug 17
AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
12:00am
8-K
EX-10.1
nm9ofoqlvk
6 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
2pomntef2no7 vo4u02
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.7
3r10jifehupx 6s
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
axhm edfdey4qv5wcf
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
2xr2qtijvp98j1t
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
hn1grp ha
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
xnxkim1wpahlrd7
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
y0l8w76 prfb6lt1wk
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
n1ybx7 01sv
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ar5tlsrmmvi mwff
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
cb6f n93v9chmu1fgr9q
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.4
hipcaae5hrg6g
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.1
98stn4o i8
2 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
paj15mxe9v
6 Apr 15
Entry into a Material Definitive Agreement
12:00am